Table 2.
Association between circulating endothelial EVs and clinical variables by repeated measures correlation
| EV population | Clinical Variable | r | 95% CI | p |
|---|---|---|---|---|
| Endothelial | HbA1c | 0.040 | -0.072, 0.164 | 0.44 |
| Mean CGM Glucose | 0.091 | -0.006, 0.186 | 0.06 | |
| % TIR (63-140mg/dl) | -0.005 | -0.129, 0.118 | 0.94 | |
| % TAR( >140mg/dl) | 0.064 | -0.060, 0.187 | 0.31 | |
| % TBR (<63mg/dl) | -0.116 | -0.236, 0.008 | 0.07 | |
| Glucose CV | -0.012 | -0.135, 0.112 | 0.85 | |
| Glucose SD | 0.054 | -0.070, 0.177 | 0.39 | |
| MAGE | 0.129 | 0.005, 0.248 | 0.04 | |
| SBP | 0.082 | -0.035, 0.196 | 0.17 | |
| DBP | 0.075 | -0.043, 0.189 | 0.21 | |
| Platelet | HbA1c | 0.009 | -0.107, 0.126 | 0.88 |
| Mean CGM Glucose | -0.111 | -0.231, 0.013 | 0.08 | |
| % TIR (63-140mg/dl) | 0.159 | 0.035, 0.276 | 0.01 | |
| % TAR( >140mg/dl) | -0.138 | -0.257, -0.014 | 0.03 | |
| % TBR (<63mg/dl) | -0.055 | -0.178, 0.068 | 0.38 | |
| Glucose CV | -0.109 | -0.229, 0.015 | 0.08 | |
| Glucose SD | -0.147 | -0.267, -0.025 | 0.02 | |
| MAGE | -0.152 | -0.271, -0.029 | 0.01 | |
| SBP | 0.051 | -0.066, 0.167 | 0.39 | |
| DBP | 0.099 | -0.017, 0.210 | 0.09 | |
| Leukocyte | HbA1c | 0.001 | -0.116, 0.116 | 0.99 |
| Mean CGM Glucose | 0.003 | -0.120, 0.127 | 0.95 | |
| % TIR (63-140mg/dl) | 0.007 | -0.116, 0.131 | 0.91 | |
| % TAR( >140mg/dl) | 0.003 | -0.121, 0.127 | 0.96 | |
| % TBR (<63mg/dl) | -0.030 | -0.154, 0.093 | 0.62 | |
| Glucose CV | 0.008 | -0.115, 0.132 | 0.89 | |
| Glucose SD | 0.013 | -0.110, 0.137 | 0.83 | |
| MAGE | 0.001 | -0.124, 0.123 | 0.99 | |
| SBP | 0.179 | 0.064, 0.289 | 0.002 | |
| DBP | 0.200 | 0.093, 0.315 | 0.001 |
Significant relationships are bolded
CGM continuous glucose monitoring, TIR time in range, TAR time above range, TBR time below range, CV coefficient of variation, SD standard deviation, MAGE mean amplitude of glycemic excursion, SBP systolic blood pressure, DBP diastolic blood pressure